Longboard Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $8 |
Gross Profit | -2 | -1 | 7 |
EBITDA | -25,641 | -18,109 | -15,572 |
EBIT | -25,643 | -18,110 | -15,573 |
Net Income | -21,785 | -14,986 | -15,033 |
Net Change In Cash | 0 | 0 | 8 |
Free Cash Flow | -19,131 | -15,177 | -11,028 |
Cash | 14,599 | 54,395 | 14,331 |
Basic Shares | 38,880 | 35,321 | 23,924 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5 | -5 | -1 | |
EBITDA | -56,754 | -44,793 | -27,838 | -14,400 |
EBIT | -56,759 | -44,798 | -27,839 | -14,400 |
Net Income | -54,422 | -43,092 | -27,733 | -14,400 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -55,571 | |||
Free Cash Flow | -50,868 | -38,063 | -24,721 | -3,442 |
Cash | 14,331 | 10,775 | 66,346 | 55,316 |
Basic Shares | 22,726 | 17,150 | 17,070 | 17,666 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.63 |
2024-06-30 | -$0.56 |
2024-03-31 | -$0.42 |
2023-12-31 | -$0.62 |
